Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with ...

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

The massive AI deals and capital spending plans announced by some of the top technology companies have stunned many on Wall ...

South Koreans love this procedure which lifts drooping mouth for an effortless, Joker-like permanent smile. As Samsung ...

Merck MRK is facing persistent challenges for its second-largest product, Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s sales ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Forget the wealthy. Why this value manager is betting on average Americans, and the stocks he's buying now. When stocks start to crumble, Smead Capital Management's Bill Smead says investors need to ...

Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...

Merck & Co., Inc. finds itself at a pivotal point as recent events stir the pot in the pharmaceutical landscape. With the ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

US healthcare st‌ocks have been u⁠nder moun⁠ting pressure this year, largel⁠y⁠ due to po‍licies​ introduce‌d b‍y the Tr​u‌m‍p ...